PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.46%
Negative revenue growth while Insurance - Life median is 4.55%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-30.46%
Negative gross profit growth while Insurance - Life median is 4.50%. Seth Klarman would suspect poor product pricing or inefficient production.
30.31%
EBIT growth exceeding 1.5x Insurance - Life median of 15.47%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
30.31%
Operating income growth exceeding 1.5x Insurance - Life median of 15.47%. Joel Greenblatt would see if unique processes drive exceptional profitability.
64.01%
Net income growth exceeding 1.5x Insurance - Life median of 9.71%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
64.05%
EPS growth exceeding 1.5x Insurance - Life median of 10.17%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
64.06%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 10.17%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.88%
Positive OCF growth while Insurance - Life median is negative. Peter Lynch might see a strong relative advantage in operational efficiency.
22.88%
Positive FCF growth while Insurance - Life median is negative. Peter Lynch might view this as a notable advantage over peers.
71.19%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 22.69%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
-40.03%
Negative 5Y CAGR while Insurance - Life median is 8.58%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
135.10%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 16.27%. Joel Greenblatt might see a short-term competitive advantage at play.
158.57%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 10.67% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
270.20%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 22.08%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
137.41%
3Y OCF/share growth > 1.5x Insurance - Life median of 6.23%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
16.15%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 1.65% over a decade. Joel Greenblatt might see a standout compounder of earnings.
188.49%
5Y net income/share CAGR > 1.5x Insurance - Life median of 23.40%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
22.03%
3Y net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm expansions or margin boosts drive the short-term advantage.
77.91%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 39.85% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
72.46%
5Y equity/share CAGR > 1.5x Insurance - Life median of 28.70%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
60.38%
3Y equity/share CAGR > 1.5x Insurance - Life median of 27.49%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.69%
AR growth of 10.69% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
2.21%
Asset growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai sees if expansions are strategic and well-supported by end demand.
2.20%
75-90% of Insurance - Life median. John Neff calls for higher ROE or more effective capital usage to match peers.
0.28%
Debt growth of 0.28% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
8.52%
Our SG&A slightly up while Insurance - Life is cutting. Peter Lynch wonders if we overspend or if the median underinvests in marketing.